findmyKOL
Clinical trialNCT00000579CompletedPhase 3Interventional

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

SponsorNational Heart, Lung, and Blood Institute (NHLBI)Lung DiseasesRespiratory Distress Syndrome, Adult
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

United States
  • University of California

    San Francisco, California, United States

  • University of Colorado Health Sciences Center

    Denver, Colorado, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Louisiana State University

    New Orleans, Louisiana, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Baystate Medical Center

    Springfield, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Mayo Foundation

    Rochester, Minnesota, United States

  • Duke University

    Durham, North Carolina, United States

  • Wake Forest University

    Winston-Salem, North Carolina, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • University of Texas

    San Antonio, Texas, United States

  • Latter Day Saints Hospital

    Salt Lake City, Utah, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 1994
Primary completion
—
Completion
31 Jul 2004
Last update posted
23 Mar 2016
Registered enrollment
—
Registry id
NCT00000579

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.